Feedback / Questions
CD30.CAR-T cell therapy - Tessa Therap, UNC Lineberger Comprehensive Cancer Center, Baylor Scott & White Research Institute
https://www.globenewswire.com/news-release/2021/12/13/2351226/0/en/Tessa-Therapeutics-Announces-Positive-Data-from-Phase-2-Trial-of-Autologous-CD30-CAR-T-Therapy-TT11-in-Relapsed-or-Refractory-Classical-Hodgkin-Lymphoma-at-2021-ASH-Annual-Meeting.html
Dec 13, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next